Nuvation Bio NUVB

$ 2.74 1.11%

Quarterly report 2024-Q3
added 11-06-2024

Nuvation Bio Balance Sheet 2011-2024 | NUVB

Annual Balance Sheet Nuvation Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-38.6 M	-96.8 M	-129 M	-908 K	-	-	-	-	-	-	-	-	-
Long Term Debt	2.04 M	3.05 M	2.19 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.97 M	1.21 M	863 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	14 M	13.2 M	16.9 M	2.8 M	-	-	-	-	-	-	-	-	-
Total Liabilities	16.4 M	17.1 M	30.2 M	2.8 M	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-343 M	-267 M	-163 M	-3.05 M	-	-	-	-	-	-	-	-	-
Total Assets	621 M	672 M	776 M	145 M	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	42.6 M	101 M	132 M	908 K	-	-	-	-	-	-	-	-	-
Book Value	605 M	655 M	746 M	142 M	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	605 M	655 M	746 M	215 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Nuvation Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	985 K	972 K	1.51 M	2.04 M	2.55 M	2.39 M	2.73 M	3.05 M	3.37 M	-	2.09 M	2.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	68.9 M	62.7 M	19.1 M	16.4 M	19.3 M	16.8 M	16 M	17.1 M	18.6 M	-	28.2 M	30.2 M	28.4 M	25.3 M	25.7 M	6.71 M	6.71 M	6.71 M	6.71 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	12.9 M	12.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-861 M	-820 M	-358 M	-343 M	-329 M	-309 M	-289 M	-267 M	-246 M	-	-184 M	-163 M	138 M	116 M	96.4 M	-76 M	76 M	76 M	76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	572 M	595 M	613 M	621 M	631 M	641 M	657 M	672 M	686 M	-	752 M	776 M	798 M	814 M	832 M	222 M	222 M	222 M	222 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	30 M	34.3 M	34.5 M	42.6 M	24.4 M	50.1 M	30.1 M	101 M	139 M	102 M	106 M	132 M	345 M	450 M	639 M	29.8 M	29.8 M	29.8 M	29.8 M	3.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	503 M	532 M	594 M	605 M	612 M	625 M	641 M	655 M	668 M	-	724 M	746 M	769 M	789 M	806 M	215 M	215 M	215 M	215 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	503 M	257 M	594 M	605 M	612 M	625 M	641 M	655 M	668 M	693 M	724 M	746 M	769 M	789 M	806 M	215 M	215 M	215 M	215 M	118 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency